ClinicalThought

Share

Program Content

Activities

  • HER2 BC New Findings
    How We Are Integrating New Findings Into Treatment for HER2-Positive Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 10, 2022

    Expires: May 09, 2023

  • HER2-Pos Brain Mets in BC
    Treating Brain Metastases in HER2-Positive Breast Cancer: Progress at Last!
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 03, 2023

    Expires: January 02, 2024

Faculty

cover img faculity

Aditya Bardia, MD, MPH, FASCO

Program Director, Breast Medical Oncology
Assistant Chief (Translational Research), Division of Hematology-Oncology
Professor of Medicine, Geffen School of Medicine, University of California Los Angeles
Director of Translational Research Integration, UCLA Health Jonsson Comprehensive Center
Los Angeles, California

cover img faculity

Kayla Douglas, PharmD

Director of Pharmacy
Mississippi Center for Advanced Medicine
Madison, Mississippi

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Danielle Roman, PharmD, BCOP

Manager, Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Puma Biotechnology, Inc.

Seagen Inc.

Partners

Smart Patients

ProCE Banner